Cercar
27/10/2021
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
Pope, MK, Hall, TS, Schirripa, V, Radic, P, Virdone, S, Pieper, KS, Le Heuzey, JY, Jansky, P, Fitzmaurice, DA, Cappato, R, Atar, D, Camm, AJ, Kakkar, AK, Viñolas, X., GARFIELD-AF Investigators. Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data. BMJ-British Medical Journal. 2021; 375DOI:10.1136/bmj-2021-066450. PMID:34706884. IF:96.216(Q1/1D).
01/10/2021
Abluminus DES: a step forward in the fight against diabetes?
Asmarats, L, Shoeib, O, Cortese, B. Abluminus DES: a step forward in the fight against diabetes?. Minerva Cardiology And Angiology. 2021; 69(5)DOI:10.23736/S2724-5683.20.05565-6. PMID:33427428. IF:2.269(Q3/8D).
22/11/2022
Distinct spectral dynamics of implanted cardiac defibrillator signals in spontaneous termination of polymorphic ventricular tachycardia and fibrillation in patients with electrical and structural diseases
Calvo, D, Salinas, L, Martinez-Camblor, P, Garcia-Iglesias, D, Alzueta, J, Rodriguez, A, Romero, R, Vinolas, X, Fernandez-Lozano, I, Anguera, I, Villacastin, J, Bodegas, A, Fontenla, A, Jalife, J, Berenfeld, O. Distinct spectral dynamics of implanted cardiac defibrillator signals in spontaneous termination of polymorphic ventricular tachycardia and fibrillation in patients with electrical and structural diseases. EUROPACE. 2022; 24(11)DOI:10.1093/europace/euac107. PMID:35851611. IF:6.100(Q1/3D).
01/11/2022
Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry
Vij, V, Piayda, K, Nelles, D, Gloekler, S, Galea, R, Furholz, M, Meier, B, Valgimigli, M, O'Hara, G, Arzamendi, D, Agudelo, V, Asmarats, L, Freixa, X, Flores-Umanzor, E, De Backer, O, Sondergaard, L, Nombela-Franco, L, McInerney, A, Korsholm, K, Nielsen-Kudsk, JE, Afzal, S, Zeus, T, Operhalski, F, Schmidt, B, Montalescot, G, Guedeney, P, Iriart, X, Miton, N, Saw, J, Gilhofer, T, Fauchier, L, Veliqi, E, Meincke, F, Petri, N, Nordbeck, P, Ognerubov, D, Merkulov, E, Cruz-Gonzalez, I, Gonzalez-Ferreiro, R, Bhatt, DL, Laricchia, A, Mangieri, A, Omran, H, Schrickel, JW, Rodes-Cabau, J, Sievert, H, Nickenig, G, Sedaghat, A. Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry. Clinical Research in Cardiology. 2022; 111(11)DOI:10.1007/s00392-022-02065-4. PMID:35849156. IF:5.000(Q2/4D).
13/10/2022
The blanking period after atrial fibrillation ablation: an European Heart Rhythm Association survey on contemporary definition and management
Bordignon, S, Barra, S, Providencia, R, de Asmundis, C, Marijon, E, Farkowski, MM, Anic, A, Guerra, JM, Kosiuk, J, Iliodromitis, K, Schmidt, B, Conte, G, Chun, JK, Boveda, S. The blanking period after atrial fibrillation ablation: an European Heart Rhythm Association survey on contemporary definition and management. EUROPACE. 2022; 24(10)DOI:10.1093/europace/euac131. PMID:35942585. IF:6.100(Q1/3D).
13/10/2022
Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS/LAHRS/APHRS
Boersma, LV, El-Chami, M, Steinwender, C, Lambiase, P, Murgatroyd, F, Mela, T, Theuns, DAMJ, Khelae, SK, Kalil, C, Zabala, F, Stuehlinger, M, Lenarczyk, R, Clementy, N, Tamirisa, KP, Rinaldi, CA, Knops, R, Lau, CP, Crozier, I, Boveda, S, Defaye, P, Deharo, JC, Botto, GL, Vassilikos, V, Oliveira, MM, Tse, HF, Figueroa, J, Stambler, BS, Guerra, JM, Stiles, M, Marques, M. Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS/LAHRS/APHRS. EUROPACE. 2022; 24(10)DOI:10.1093/europace/euac066. PMID:35912932. IF:6.100(Q1/3D).